Vaxart, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-13.5M | $5.2M | $-8.1M | $-15.0M | $-15.6M | $-14.1M | $-16.5M | $-24.4M |
| Depreciation & Amortization | — | $1.1M | — | — | $2.2M | — | — | $2.2M |
| Depreciation | $800.0K | $900.0K | $900.0K | $900.0K | $900.0K | $1.0M | $900.0K | $900.0K |
| Amortization | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K | $100.0K | $200.0K | $200.0K |
| Stock-Based Compensation | — | $1.5M | — | — | $2.5M | — | — | $4.1M |
| Net Cash from Operating Activities | $2.8M | $-2.1M | $2.6M | $-15.9M | $-9.6M | $-4.2M | $-12.0M | $-21.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $35.0K | $448.0K | $117.0K | $-103.0K | $130.0K | $9.0K | $370.0K | $131.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $-676.0K | — | — | $13.2M | — | — | $-5.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-338.0K | — | — | $-164.0K | — | — | $18.2M |
| Net Change in Cash | — | $-3.1M | — | — | $3.5M | — | — | $-8.0M |
| Free Cash Flow | $2.7M | $-2.5M | $2.5M | $-15.8M | $-9.7M | $-4.2M | $-12.4M | $-21.3M |